Blackstone to buy Japanese specialty pharmaceutical firm Ayumi

04:36 EDT 18 Mar 2019 | Pharmaceutical Business Review

Based in Tokyo, Ayumi is engaged in the manufacturing and marketing of various drug products for anti-rheumatism and orthopedic pain management. Citing a person familiar with the matter,

The post Blackstone to buy Japanese specialty pharmaceutical firm Ayumi appeared first on Pharmaceutical Business review.

Original Article: Blackstone to buy Japanese specialty pharmaceutical firm Ayumi

More From BioPortfolio on "Blackstone to buy Japanese specialty pharmaceutical firm Ayumi"